Zdrowie i gospodarka · 21/07/1997

Animal Drugs, Feeds, and Related Products

The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions reflecting approval of one new animal drug application (NADA) held by Babineaux's Veterinary Products for diethylcarbamazine citrate syrup, and two NADA's held by Schein Pharmaceutical/Steris Laboratories for phenylbutazone injection and oxytocin injection. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of these NADA's as requested by their sponsors.